Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion

Galderma

Status: Completed

Conditions: Skin Irritation

Treatments: Other: Cetaphil Moisturizing Lotion Daily Advance

Study type: Interventional

Funder types: Industry

Identifiers

NCT01892423

GLI.04SPR.US10044

Details and patient eligibility

About

Human repeat insult patch test to assess the potential for Cetaphil Moisturizing Lotion Daily Advance to induce sensitization to the skin

Enrollment: 146 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 18-65 years
• Good health
• willingness to cooperate and participate
• willingness to avoid topical products at test sites
• willingness to avoid direct sun exposure to test sites

Exclusion criteria

• Individuals with active psoriasis or eczema
• individuals with sunburn, acne, abrasions, scar tissue, or tattoos on test sites, or disease of skin that might interfere
• individuals who have had a mastectomy with axillary nodes were removed
• individuals receiving anticancer, immunosuppressive treatments or medications, or radiation
• pregnant, nursing, or planned to become pregnant
• use of topical steroids or drugs at test sites
• active or untreated skin cancer
• active hepatitis
• current routine or frequent use of high doses of anti-inflammatory drugs
• individuals who have had les than two week rest period since completion of previous patch testing on upper back or upper arms
• individuals with uncontrolled metabolic diseases

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

146 participants in 1 patient group

Cetaphil Moisturizing Lotion Daily Advance

Experimental group

Description:

Each subject had Cetaphil Moisturizing Lotion Daily Advance applied

Treatment:

Other: Cetaphil Moisturizing Lotion Daily Advance